A REVIEW OF NOVEL APPROACH IN BILAYER TABLET TECHNOLOGY NOVEL APPROACH IN BILAYER TABLET TECHNOLOGY
Main Article Content
Abstract
Over the past 30 years as the expense and complications involved in marketing new drug entities have increased, with concomitant recognition of the therapeutic advantages of controlled drug delivery, greater attention has been focused on development of sustained or controlled release drug delivery systems. Bilayer tablet is new era for the successful development of controlled release formulation along with various features to provide a way of successful drug delivery system. . So use of bilayer tablet is a very different aspect for anti-inflammatory and analgesic. Bi-layer tablet is suitable for sequential release of two drugs in combination, separate two incompatible substances and also for sustained release tablet in which one Layer is immediate release as initial dose and second layer is maintenance dose. Bilayer tablet is improved beneficial technology to overcome the shortcoming of the single layered tablet. Several pharmaceutical companies are currently developing bi-layer tablets. For a variety of reasons: patent extension, therapeutic, marketing to name a few. To reduce capital investment, quite often existing but modified tablet presses are used to develop and produce such tablets. This article explains about different techniques of bilayer tablet and why the development and production of quality bi-layer tablets needs to be carried out on purpose-built tablet presses to overcome common bi-layer problems, such as layer-separation, insufficient hardness, Inaccurate individual layer weight control, cross-contamination between the layers, reduced yield etc.
Downloads
Article Details
How to Cite
References
Shiyani B, Gattani S, Surana S. Formulation and evaluation of bi-layer tablet of Metoclopramide
hydrochloride and Ibuprofen. AAPS Pharm Sci Tech 2008;9(3):818-27.
Pranjal Kumar Singh, Sanjoo Kumar Bilayer and Floating Bioadhesive Tablets: Innovative approach to Gastroretention, Journal of Drug Delivery & Therapeutics; 2011, 1(1): 32-35
Kulkarni A, Bhatia M. Development and evaluation of bilayer floating tablets of atenolol and lovastatin for biphasic release profile. Iran. J. Pharm. Res. 2009; 8: 15–25.
Nirmal J, Saisivam S, Peddanna C, Muralidharan S, Nagarajan M, et al. Bilayer tablets of atorvastatin calcium and nicotinic acid: formulation and evaluation. Chem. Pharm. Bull. 2008; 56: 1455–1458,26-102-1 PB
Sachin S. Kale, Viraj S. Saste, Bilayer Tablet, International Journal of Pharmaceutical Sciences Review and Research, vol 9,article 005,2011
Rajan K. Verma and Sanjay Garg, “Current Status of Drug Delivery Technologies and Future Directions,” Pharmaceutical Technology On-Line, 25 (2), 1–14 (2001).
Divya .A, K. Kavitha, M. Rupesh Kumar Journal of Applied Pharmaceutical Science 01 (08); 2011: 43-47
Kale SS, Saste VS, Prajkta L, Ughade, Dheeraj T, Bhaviskar. Bilayer tablet:Review. Int J Pharm Sci Rev and Res 2011;9(1):25-30.
Tod R. Hamachek, innovative oral drug delivery technologies, Penwest Pharmaceuticals Co.,2002
Pederson AV. Erosion-based drug delivery. Manuf. Chem. 2006; 11:1–6.
Timmins et al. Biphasic controlled release system for high solubility pharmaceuticals and method.United States Patent 64, 75, 521. 5th November 2002.
Patel Mehul,Ganesh Nanjan Sockan, Challenges in the Formulation of Bilayered Tablets: A Review, International Journal of Pharma Research and Development, ISSN 0974 – 9446,2010
Jan Vogeleer. Bi-layer tablets - why special technology is required The Courtoy-R292F tablet press, designed for quality bi-layer tablets Niro Pharma Systems
Rudnic EM, Kottke MK Tablet dosage form. In Banker GS, Rhodes CT, editors. Modern Pharmaceutics. 3rd ed., vol 72. New York: Marcel Dekker Inc. p 369.
Breech AJ, Lucisano L J, Franz RM. Investigation into substrate cracking of a film coated bilayered tablet. J. Pharm. Pharmacol. 1998; 40:282-283.
M.A. Kalam, M. Humayun, N. Parvez, S.Yadav, A.Garg, S.Amin ,Y. Sultana1and A. Ali.,Continental J. Pharmaceutical Sciences 1: 30 - 35, 2007
Li S.P., Karth M.G., Feld K.M., Pendharkar C.M., Willams R.O., Evaluation of Bilayer tablet machines. A Case study. Drug Dev. Ind. Pharm. 1995; 21(5): 571 590.
Abshagen U, Spo ¨rl-Radun S, First data on the effects and pharmacokinetics of isosorbide-5-mononitrate in normal man, Eur. J. Clin.Pharmacol. 19, 1981 p.423–429.
Hutt V, Bonn R, Fritschi E, Jaeger H, Evaluation of the pharmacokinetics and absolute bioavailability of thre isosorbide- 5-mononitrate preparation in healthy volunteers, Arzneim.-Forsch./Drug Res. 19,1995, p.142–145.